ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 147 filers reported holding ANI PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 10.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,661,260 | -24.1% | 218,072 | -29.6% | 0.31% | -20.6% |
| Q2 2023 | $16,681,217 | +48.6% | 309,887 | +9.6% | 0.39% | +17.9% |
| Q1 2023 | $11,225,706 | -22.6% | 282,621 | -21.6% | 0.33% | -19.3% |
| Q4 2022 | $14,502,674 | +31.8% | 360,494 | +5.3% | 0.41% | +26.2% |
| Q3 2022 | $11,006,000 | +128.9% | 342,450 | +111.3% | 0.32% | +140.0% |
| Q2 2022 | $4,809,000 | +79.9% | 162,074 | +183.8% | 0.14% | +164.7% |
| Q2 2017 | $2,673,000 | -34.3% | 57,115 | -30.5% | 0.05% | -28.2% |
| Q1 2017 | $4,069,000 | +705.7% | 82,177 | +447.8% | 0.07% | +610.0% |
| Q1 2016 | $505,000 | -92.0% | 15,000 | -92.5% | 0.01% | -91.6% |
| Q1 2014 | $6,309,000 | +127.8% | 201,231 | +45.9% | 0.12% | +133.3% |
| Q4 2013 | $2,770,000 | +156.7% | 137,944 | +24.9% | 0.05% | +142.9% |
| Q3 2013 | $1,079,000 | – | 110,447 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |